1973
DOI: 10.1136/bmj.4.5890.449
|View full text |Cite
|
Sign up to set email alerts
|

High Dose Frusemide in Established Acute Renal Failure

Abstract: SummaryThe results of treatment with frusemide in 105 patients with established acute renal failure admitted during the past six years were reviewed and compared with control groups. Daily doses of2,000 mg of frusemide administered from the day of admission onwards produced a significant increase in the number of patients who attained a diuresis and decreased the duration of oliguria.The reduction in the time spent in hospital and in the number of dialyses required suggests that the use of frusemide in these l… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
31
0
6

Year Published

1983
1983
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 110 publications
(40 citation statements)
references
References 3 publications
3
31
0
6
Order By: Relevance
“…Therefore, oliguria is an important predictive characteristic of acute renal failure, and worse prognosis in oliguric ARF cases has been demonstrated in many series. 22,23,[34][35][36][37][38] The mortality observed among our patients was high (62.5%) and in accordance with other studies, in which mortality ranged from 50 to 90% among critically ill patients with ARF. 1,8 Liaño et al, 22 in a prospective study, found higher mortality among patients with ARF in the ICU (69.9%), in comparison with patients from clinical (42.8%), surgical (36.3%) and nephrology wards (18.1%).…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…Therefore, oliguria is an important predictive characteristic of acute renal failure, and worse prognosis in oliguric ARF cases has been demonstrated in many series. 22,23,[34][35][36][37][38] The mortality observed among our patients was high (62.5%) and in accordance with other studies, in which mortality ranged from 50 to 90% among critically ill patients with ARF. 1,8 Liaño et al, 22 in a prospective study, found higher mortality among patients with ARF in the ICU (69.9%), in comparison with patients from clinical (42.8%), surgical (36.3%) and nephrology wards (18.1%).…”
Section: Discussionsupporting
confidence: 89%
“…Many studies have not shown any signifi cant benefi t from the use of diuretics for ARF cases. [31][32][33][34][35][36][37][38][39][40] In a recent study by Mehta et al, 41 it was demonstrated that the use of loop diuretics was associated with a 77% increase in the risk of death and non-recovery of renal function. The severity of ARF might be underestimated when the urine output is sustained, which may lead to a delay in instituting dialytic treatment.…”
Section: Discussionmentioning
confidence: 99%
“…However, clinical studies gave contradictory results [17,18] and recently a metaanalysis showed that the overall preventive effect of theophylline against CN was modest and probably clinically non-significant [19]. Furosemide has the potential to protect the kidneys in the face of renal insults but clinical studies in different models of acute renal failure including CN did not demonstrate a protective effect [20][21][22][23]. But the use of furosemide in the setting of CN prevention by volume expansion can reduce the risk of fluid overload.…”
Section: Introductionmentioning
confidence: 99%
“…In patients with established ARF, several studies have found no benefit of loop diuretics (27)(28)(29)(30)(31)(32)(33) (Table 1). More particularly, loop diuretics did not accelerate renal recovery, reduce the need for dialysis, or decrease mortality.…”
Section: Diureticsmentioning
confidence: 99%